1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Ovarian Cancer Research Program (OCRP) Investigator-Initiated Research Award (FY26) is sponsored by Department of Defense (DoD), Congressionally Directed Medical Research Programs (CDMRP). This award supports high-impact research addressing a critical need with the potential for important contributions to ovarian cancer or patient/survivor care.
Research projects may range from basic laboratory research to translational research, excluding clinical trials. Preliminary data are required.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Investigators. Partnering PI Option: Up to two investigators may collaborate on a single application, each serving as a PI and receiving a separate award. Confirm the full requirements in the official notice before applying.
Ovarian Cancer Research Program (OCRP) Investigator-Initiated Research Award (FY26) is funded by Department of Defense (DoD), Congressionally Directed Medical Research Programs (CDMRP). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
Past winners and funding trends for this program
CDMRP's FY26 portfolio funds 34 programs, and October 2026 is dense with full-application deadlines: PRCRP October 5, PCRP October 7, MRP October 14. Every one of them is gated behind a pre-application that closed months earlier. Here is what that two-step structure actually costs applicants, and how to be inside the gate for FY27.
Read articleCDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read articleThe memorandum of agreement was signed August 4 and 5, disclosed by House appropriators on September 3, and runs through 2036. It names no dollar figure. Here is what is actually established, what is still speculation, and what researchers holding or planning NIAID biodefense awards should do before September 30.
Read article